Search research articles
Contact Us
Filters
Showing results (21-30 of 66) with videos related to
Page
of 7
Sort By:
American Journal of Clinical Oncology
|
August 5, 2014
Etoposide, Methotrexate, and Dactinomycin Alternating With Cyclophosphamide and Vincristine (EMACO) for Male Patients With HCG-expressing, Chemoresistant Germ Cell Tumors
Daniele Raggi, Patrizia Giannatempo, Rosalba Miceli, et al.
Urology Practice
|
December 24, 2025
Incarcerated Patients Present with More Advanced Bladder Cancer Stage: A Statewide Analysis
Carlo Silvani, Alfonso Santangelo, Jack Considine, et al.
World Journal of Urology
|
April 15, 2026
Cancer-specific mortality differences between radical prostatectomy and radiotherapy after biochemical recurrence: analysis of a health system-wide cohort
Carlo Silvani, Alfonso Santangelo, Alex Stephens, et al.
The Journal of Urology
|
November 23, 2013
The relationship between characteristics of inguinal lymph nodes and pelvic lymph node involvement in penile squamous cell carcinoma: a single institution experience
Giovanni Lughezzani, Mario Catanzaro, Tullio Torelli, et al.
Tumori
|
January 14, 2017
Surgery of locally advanced and metastatic kidney cancer after tyrosine kinase inhibitors therapy: single institute experience
Alberto De Gobbi, Davide Biasoni, Mario Catanzaro, et al.
Urologic Oncology
|
July 2, 2017
Adjuvant pelvic radiation is associated with improved survival and decreased disease recurrence in pelvic node-positive penile cancer after lymph node dissection: A multi-institutional study
Dominic H Tang, Rosa Djajadiningrat, Gregory Diorio, et al.
Clinical Genitourinary Cancer
|
October 29, 2013
Combination of paclitaxel, cisplatin, and gemcitabine (TPG) for multiple relapses or platinum-resistant germ cell tumors: long-term outcomes
Andrea Necchi, Nicola Nicolai, Luigi Mariani, et al.
The Journal of Urology
|
April 30, 2013
Persistent CD30 expression by embryonal carcinoma in the treatment time course: prognostic significance of a worthwhile target for personalized treatment
Patrizia Giannatempo, Biagio Paolini, Rosalba Miceli, et al.
Cancers
|
June 2, 2021
Prediction of Grade Reclassification of Prostate Cancer Patients on Active Surveillance through the Combination of a Three-miRNA Signature and Selected Clinical Variables
Paolo Gandellini, Chiara Maura Ciniselli, Tiziana Rancati, et al.
The Journal of Urology
|
May 6, 2021
Reply by Authors
Sebastiano Nazzani, Mario Catanzaro, Davide Biasoni, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 66) with videos related to
Sort By:
Page
of 7
American Journal of Clinical Oncology
|
August 5, 2014
Etoposide, Methotrexate, and Dactinomycin Alternating With Cyclophosphamide and Vincristine (EMACO) for Male Patients With HCG-expressing, Chemoresistant Germ Cell Tumors
Daniele Raggi, Patrizia Giannatempo, Rosalba Miceli, et al.
Urology Practice
|
December 24, 2025
Incarcerated Patients Present with More Advanced Bladder Cancer Stage: A Statewide Analysis
Carlo Silvani, Alfonso Santangelo, Jack Considine, et al.
World Journal of Urology
|
April 15, 2026
Cancer-specific mortality differences between radical prostatectomy and radiotherapy after biochemical recurrence: analysis of a health system-wide cohort
Carlo Silvani, Alfonso Santangelo, Alex Stephens, et al.
The Journal of Urology
|
November 23, 2013
The relationship between characteristics of inguinal lymph nodes and pelvic lymph node involvement in penile squamous cell carcinoma: a single institution experience
Giovanni Lughezzani, Mario Catanzaro, Tullio Torelli, et al.
Tumori
|
January 14, 2017
Surgery of locally advanced and metastatic kidney cancer after tyrosine kinase inhibitors therapy: single institute experience
Alberto De Gobbi, Davide Biasoni, Mario Catanzaro, et al.
Urologic Oncology
|
July 2, 2017
Adjuvant pelvic radiation is associated with improved survival and decreased disease recurrence in pelvic node-positive penile cancer after lymph node dissection: A multi-institutional study
Dominic H Tang, Rosa Djajadiningrat, Gregory Diorio, et al.
Clinical Genitourinary Cancer
|
October 29, 2013
Combination of paclitaxel, cisplatin, and gemcitabine (TPG) for multiple relapses or platinum-resistant germ cell tumors: long-term outcomes
Andrea Necchi, Nicola Nicolai, Luigi Mariani, et al.
The Journal of Urology
|
April 30, 2013
Persistent CD30 expression by embryonal carcinoma in the treatment time course: prognostic significance of a worthwhile target for personalized treatment
Patrizia Giannatempo, Biagio Paolini, Rosalba Miceli, et al.
Cancers
|
June 2, 2021
Prediction of Grade Reclassification of Prostate Cancer Patients on Active Surveillance through the Combination of a Three-miRNA Signature and Selected Clinical Variables
Paolo Gandellini, Chiara Maura Ciniselli, Tiziana Rancati, et al.
The Journal of Urology
|
May 6, 2021
Reply by Authors
Sebastiano Nazzani, Mario Catanzaro, Davide Biasoni, et al.
Page
of 7